Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

PaperCitations, authors & open-access status

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 488 citations, 2022 year and hybrid oa status.

488
Citations
2022
Year
hybrid
OA Status

Related on ScholarIQ

Paul DiSilvestro
Author
Michael Friedländer
Author
Giovanni Scambia
Author
Carol Aghajanian
Author
Amit M. Oza
Author
Antonio González-Martı́n
Author
470M+ articles · free account